These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2899349)

  • 1. [The value of an in vitro method of granulomonocytic colonies for the diagnosis and prognosis of myelodysplastic syndromes].
    Grigoriu G; Puşcariu T; Ursea C; Munteanu N; Butoianu E; Coliţă A; Popp A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):61-8. PubMed ID: 2899349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of the in vitro culture of granulomonocytic germ cells (CFU-GM) in myelodysplastic syndromes].
    Florensa L; Woessner S; Lafuente R; Almarcha J; Sans-Sabrafen J
    Sangre (Barc); 1985; 30(4-C):689-97. PubMed ID: 3867159
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
    Tennant GB; Jacobs A; Bailey-Wood R
    Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clonal culture of hematopoietic cells in patients with the myelodysplastic syndrome].
    Jelínek J; Neuwirt J; Neuwirtová R
    Vnitr Lek; 1986 Mar; 32(3):222-7. PubMed ID: 3962203
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytodynamics of myeloid precursors (divisible erythroblasts and granulocytes) in myelodysplastic syndromes].
    Sánchez Fayos J; Outeiriño J; Calabuig T; Prieto E; Pérez-Sánchez I; Lapuente L; Escudero A
    Sangre (Barc); 1985; 30(4-C):698-704. PubMed ID: 4089739
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelodysplastic syndrome: morphological aspects of dysmyelopoiesis].
    Koike T; Takahashi M
    Rinsho Ketsueki; 1986 Sep; 27(9):1752-64. PubMed ID: 3806984
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro functions of stromal cells from human and mouse bone marrow.
    Zipori D; Reichman N; Arcavi L; Shtalrid M; Berrebi A; Resnitzky P
    Exp Hematol; 1985 Aug; 13(7):603-9. PubMed ID: 4029289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow cultures and prognosis in primary myelodysplastic syndromes.
    Korthout M; De Bock R; van Bockstaele D; Peetermans M
    Leuk Res; 1990; 14(1):85-9. PubMed ID: 2304356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
    Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
    Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
    [No Abstract]   [Full Text] [Related]  

  • 11. [Qualitative and quantitative evaluation of CFU-E colonies in myelodysplastic syndromes].
    Maruo N; Ozawa M; Kimura S; Kondo M; Fujita S; Fukuda M
    Rinsho Byori; 1991 Dec; 39(12):1342-6. PubMed ID: 1779472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biology and clinical aspects of primary myelodysplastic syndromes].
    Urbańska-Ryś H; Robak T; Krykowski E
    Pol Tyg Lek; 1988 Feb; 43(7):225-9. PubMed ID: 3043403
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between cultures of granulocytic progenitor cells from bone marrow and from peripheral blood in acute leukemias. Preliminary report.
    Gorini M; Ghizzi A; Tacchini V
    Haematologica; 1979 Oct; 64(5):570-9. PubMed ID: 116917
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
    Nagler A; Rikilis I; Tatarsky I; Fabian I
    J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and clinical variations in the myelodysplastic syndromes.
    Jacobs A; Clark RE
    Clin Haematol; 1986 Nov; 15(4):925-51. PubMed ID: 3552349
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelodysplastic syndrome: a review of 35 patients.
    Bursztyn M; Douer D; Ramot B
    Isr J Med Sci; 1987 Nov; 23(11):1140-4. PubMed ID: 3436796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content of granulocytes, monocytes, and lymphocytes in the bone marrow smears of patients with myelodysplastic syndromes.
    Widell S; Hast R; Cox C; Auer G; Bennett JM
    Am J Hematol; 2001 Jun; 67(2):112-8. PubMed ID: 11343383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Panmyelopathy and myeloproliferative syndrome].
    Jorke D; Bach G
    Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
    Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
    Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.